Related Experiment Video
Updated: Jan 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Update on Screening for Sight-Threatening Diabetic Retinopathy.
Peter H Scanlon1,2,3,4
1Clinical Director English NHS Diabetic Eye Screening Programme, Cheltenham, United Kingdom, p.scanlon@nhs.net.
Recent advances in diabetic retinopathy screening technology show promise for improving sight-saving programs. Further studies must confirm the effectiveness and cost-effectiveness of these new diagnostic tools before widespread adoption.
Area of Science:
- Ophthalmology
- Medical Technology
- Public Health
Background:
- Diabetic retinopathy is a leading cause of preventable blindness.
- Early detection through screening is crucial for timely intervention.
- Technological advancements offer potential improvements in screening efficiency and accuracy.
Purpose of the Study:
- To review recent technological advancements in diabetic retinopathy screening.
- To evaluate the effectiveness and cost-effectiveness of these new technologies.
Main Methods:
- Systematic literature search using Zetoc database.
- Inclusion of articles on screening and management of diabetic retinopathy.
- Analysis of studies assessing technological effectiveness and cost-effectiveness.
Main Results:
- Exploration of various technologies including digital photography alternatives, camera size, and field of view.
- Discussion on mydriasis protocols, visual acuity measurement, and image grading.
- Assessment of automated grading analysis and overall cost-effectiveness.
Conclusions:
- Numerous technological innovations exist for diabetic retinopathy screening.
- Each new technology requires rigorous validation of its effectiveness and cost-effectiveness.
- Widespread adoption hinges on demonstrated clinical and economic benefits.
Related Concept Videos
Sight Distance in a Vertical Curve
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications

